Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI) investors of a class action representing investors that bought securities between October 30, 2024 and November 26, 2024, inclusive (the "Class Period"). Acadia Healthcare investors have until February 3, 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
According to the complaint, the Company made false and misleading statements to the public. ASP Isotopes misrepresented the effectiveness of its enrichment technology to investors. The Company inaccurately promoted the potential of its high-assay low-enriched uranium facility. Additionally, it overstated the performance of its nuclear fuels operating segment. As a result, the Company's public statements were false and materially misleading throughout the class period. When the truth about ASP Isotopes was revealed, investors incurred financial losses.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
